Stock Overview
BioNTech SE (BNTX)
NASDAQ · Healthcare · Biotechnology
BioNTech SE is a Healthcare company with a market capitalization of $23.07B.
Market Cap
$23.07B
Forward P/E
7.0
Price/Sales
8.2
Price/Book
1.0
EV/EBITDA
32.7
Beta
1.32
EPS (TTM)
$-5.76
Profit Margin
-44.6%
ROE
-6.7%
52W High
$124.00
52W Low
$79.52
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025 · in EUR
Revenue
2.76B EUR
Gross Profit
2.14B EUR
Operating Income
-623.87M EUR
Net Income
-1.09B EUR
Free Cash Flow
269.81M EUR
Total Debt
267.38M EUR
Cash & Equivalents
7.67B EUR
Shareholder Equity
19.22B EUR
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $-1.95 | $-2.03 | +3.9% |
| Q4 2025 | March 10, 2026 | $-0.33 | $-0.25 | -33.5% |
| Q3 2025 | November 3, 2025 | $-0.12 | $0.10 | -220.0% |
| Q2 2025 | August 4, 2025 | $-1.60 | $-1.41 | -13.5% |
| Q1 2025 | May 5, 2025 | $-1.82 | $-2.35 | +22.4% |
| Q4 2024 | March 10, 2025 | $1.08 | $0.48 | +126.6% |
Other Biotechnology Stocks
Frequently Asked Questions
What is BioNTech SE's market cap?
As of June 29, 2026, BioNTech SE (BNTX) has a market capitalization of $23.07B.
Does BioNTech SE pay a dividend?
BioNTech SE does not currently pay a dividend.
What sector is BNTX in?
BioNTech SE is in the Healthcare sector, specifically the Biotechnology industry.
What was BioNTech SE's revenue?
In its latest reported fiscal year (ending December 31, 2025), BioNTech SE reported revenue of 2.76B EUR and net income of -1.09B EUR.
Ask your own questions about BNTX
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.